UDP-N-acetylglucosamine is used as a substrate for serine and tyrosine glycosylation of several transcription factors, such as plasminogen activator inhibitor-1 (PAI-1) and transforming growth factor-β1 (TGF-β1), leading to microvascular complications in diabetes [263,264]. The gene discussed is SERPINE1; the disease is diabetes mellitus.